Yangao Huo

Yangao Huo

Auto-generated profile, based on publicly available information

Yangao Huo

National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences , 15 Datun Road , Beijing 100101

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2022 in Nature
Verified
Journal Article
Closed access
PDF file
HLHuiling Li
Huiling Li
YHYangao Huo
Yangao Huo
XHXi He
Xi He
LYLiping Yao
Liping Yao
HZHao Zhang
Hao Zhang
YYYan Yuan
Yan Yuan

26 January 2023 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
YHYangao Huo
Yangao Huo
HZHongshen Zhao
Hongshen Zhao
QDQinghua Dong
Qinghua Dong
TJTao Jiang
Tao Jiang


5 September 2025 in Nucleic Acids Research
Verified
Journal Article
Open access
YXYumeng Xiao
Yumeng Xiao
JCJunyu Chen
Junyu Chen
XHXincan Hou
Xincan Hou
HWHongwei Wang
Hongwei Wang
KZKundi Zhang
Kundi Zhang
LGLichuan Gu
Lichuan Gu
Rapid and sensitive detection of RNA is important in fields such as biomedical research and clinical diagnostics. However, current methods typically involve an amplification process, require substantial time, and are susceptible to aerosol contamination. Herein, we introduce a NanoLock-powered, amplification-free assay based on the type III-E clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated system for rapid, highly sensitive, and specific RNA diagnostics. This innovative platform, designated CRISPR-guided caspase (Craspase)–NanoLock–Csx30 (CNC), harmoniously integrates the precise protease activity of Craspase with the remarkable luminescent sensitivity of NanoLock, creating a novel and streamlined approach for RNA detection. The CNC platform exhibited exceptional sensitivity in detecting severe acute respiratory syndrome coronavirus-2 N gene RNA through the integration of three guide RNAs, achieving a detection limit of 250 fM in just 10 min without amplification. Preliminary studies further revealed the platform's extended diagnostic potential for detecting influenza A virus and human immunodeficiency virus. These findings collectively establish the CNC platform as an appealing tool for infectious disease detection and significantly broaden the scope of CRISPR-based diagnostic applications.

11 January 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
HZHongtai Zhang
Hongtai Zhang
MSMingmin Shi
Mingmin Shi
XMXiaoli Ma
Xiaoli Ma
MLMengxi Liu
Mengxi Liu
NWNenhan Wang
Nenhan Wang
LBLijun Bi
Lijun Bi